342 related articles for article (PubMed ID: 28366482)
1. Monoclonal Antibodies for the Treatment of Nasal Polyps.
Willson TJ; Naclerio RM; Lee SE
Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
[TBL] [Abstract][Full Text] [Related]
2. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
3. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.
Eschenbacher W; Straesser M; Knoeddler A; Li RC; Borish L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):539-547. PubMed ID: 33012318
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody therapy in sinonasal disease.
Chiarella SE; Sy H; Peters AT
Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440
[TBL] [Abstract][Full Text] [Related]
5. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
Clottu A; Reinhard A; Comte D
Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
[TBL] [Abstract][Full Text] [Related]
6. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
7. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
8. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
9. Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps.
Groot Kormelink T; Calus L; De Ruyck N; Holtappels G; Bachert C; Redegeld FA; Gevaert P
Allergy; 2012 Sep; 67(9):1165-72. PubMed ID: 22765846
[TBL] [Abstract][Full Text] [Related]
10. Targeted Molecular Therapies in Allergy and Rhinology.
Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in Chronic Rhinosinusitis with Nasal Polyps.
Workman AD; Kohanski MA; Cohen NA
Immunol Allergy Clin North Am; 2018 Nov; 38(4):679-692. PubMed ID: 30342588
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
Schneider JS
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602
[No Abstract] [Full Text] [Related]
13. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps.
Bachert C; Hicks A; Gane S; Peters AT; Gevaert P; Nash S; Horowitz JE; Sacks H; Jacob-Nara JA
Front Immunol; 2024; 15():1356298. PubMed ID: 38690264
[TBL] [Abstract][Full Text] [Related]
14. Nasal biomarker profiles in acute and chronic rhinosinusitis.
Riechelmann H; Deutschle T; Rozsasi A; Keck T; Polzehl D; Bürner H
Clin Exp Allergy; 2005 Sep; 35(9):1186-91. PubMed ID: 16164446
[TBL] [Abstract][Full Text] [Related]
15. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
Boiko NV; Stagnieva IV; Lodochkina OE; Kurbatova NV
Vestn Otorinolaringol; 2023; 88(4):46-53. PubMed ID: 37767590
[TBL] [Abstract][Full Text] [Related]
16. Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps.
Hong H; Chen F; Sun Y; Yang Q; Gao W; Cao Y; Fan Y; Shi J; Li H
J Allergy Clin Immunol; 2018 May; 141(5):1890-1892. PubMed ID: 29337030
[No Abstract] [Full Text] [Related]
17. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
[TBL] [Abstract][Full Text] [Related]
18. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin 5 therapy for chronic rhinosinusitis with polyps.
Poblete MJ; Rosenbaum A; Winter M
Medwave; 2018 Oct; 18(6):e7301. PubMed ID: 30365483
[TBL] [Abstract][Full Text] [Related]
20. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps.
Wu X; Hong H; Zuo K; Han M; Li J; Wen W; Xu G; Miao B; Li H
Int Forum Allergy Rhinol; 2016 Jan; 6(1):75-81. PubMed ID: 26332237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
